Systematic expression analysis of genes related to multidrugresistance in isogenic docetaxel-and adriamycin-resistant breast cancer cell lines

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6143-6150

  Li, Wen Jing ^a   Zhong, Shan Liang ^b   Wu, Yuan Jian ^a   Xu, Wei Dong ^a   Xu, Jin Jin ^b   Tang, Jin Hai ^b   Zhao, Jian Hua ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Adriamycin; Breast cancer cell line; Docetaxel; MDR; Pathways

Indexed keywords

10 HYDROXYCAMPTOTHECIN; BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CISPLATIN; CYTOCHROME P450 3A4; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; GLUTATHIONE TRANSFERASE; METHOTREXATE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; TAMOXIFEN;

ARTICLE; BAX GENE; BCL 2 GENE; BCRP GENE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; CROSS RESISTANCE; CYP3A4 GENE; CYTOTOXICITY; DOSE RESPONSE; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GST PI GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MDR1 GENE; MRP1 GENE; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOPOIIALPHA GENE; TUBB3 GENE; UPREGULATION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MCF-7 CELLS; TAXOIDS;

EID: 84892735911     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2725-x     Document Type: Article

References (23)

1. Saloustros E, Mavroudis D, Georgoulias V (2008) Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Phar-macother 9(15):2603-2616
2. Rivera E, Gomez H (2010) Chemotherapy resistance in meta-static breast cancer: the evolving role of ixabepilone. Breast Cancer Res 12(Suppl 2):S2
3. Chadderton A, Villeneuve DJ, Gluck S, Kirwan-Rhude AF, Gannon BR, Blais DE, Parissenti AM (2000) Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells. Breast Cancer Res Treat 59(3):231-244
4. Germano S, O'Driscoll L (2009) Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine. Curr Cancer Drug Targets 9(3):398-418
5. Miyoshi Y, Ando A, Takamura Y, Taguchi T, Tamaki Y, Noguchi S (2002) Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int J Cancer 97(1):129-132
6. Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22(47):7369-7375
7. Hofmann Glenn A, Mattern Michael R (1993) Topoisomerase II in multiple drug resistance. Cytotechnology 12(1-3):137-154
8. Lobert S, Jefferson B, Morris K (2011) Regulation of b-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. Cyto-skeleton (Hoboken) 68(6):355-362
9. Chuna E, Lee KY (2004) Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 315(3):771-779
10. Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM (2006) cDNA microarray analysis of isogenic paclitaxel-and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat 96(1):17-39
11. Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y (2006) Estrogen-mediated post transcriptional downregulation of P-glycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci 97(11):1198-1204
12. Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92(16):1295-1302
13. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SP, Deeley RG (1995) Characterization of the M(r) 190, 000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Cancer Res 55(1):102-110
14. Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD (2004) Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res 64(14):4927-4930
15. Miyoshi Y, Taguchi T, Kim SJ, Tamaki Y, Noguchi S (2005) Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers. Breast Cancer 12(1):11-15
16. Sakurai K, Enomoto K, Matsuo S, Amano S, Shiono M (2011) CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer. Surg Today 41(5):674-679
17. Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z, Gao F, Kong Y, Xiao GG, Wang Q (2011) Expression of P-gp, MRP, LRP, GST-p and TopoIIa and intrinsic resistance in human lung cancer cell lines. Oncol Rep 26(5):1081-1089
18. Stengel C, Newman SP, Leese MP, Potter BV, Reed MJ, Purohit A (2010) Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer 102(2):316-324
19. Mongroo PS, Rustgi AK (2010) The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 10(3):219-222
20. Ferlini C, Scambia G, Distefano M, Filippini P, Isola G, Riva A, Bombardelli E, Fattorossi A, Benedetti Panici P, Mancuso S (1997) Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis. Br J Cancer 75(6):884-891
21. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1324-1337
22. Driák D, Dvorská M, Svandová I, Sehnal B, Benková K, Spur-ková Z, Halaska M (2011) Changes in expression of some apoptotic markers in different types of human endometrium. Folia Biol (Praha) 57(3):104-111
23. Işeri OD, Kars MD, Gündüz U (2012) Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern. Mol Biol Rep 39(4):3505-3516